1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of niraparib in older patients with advanced ovarian cancer (OC): Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Meeting Abstract

    Heitz, F.; Valabrega, G.; Pothuri, B.; Oaknin, A.; Graybill, W.; Sanchez, A. B.; McCormick, C.; Baurain, J. F.; Hoskins, P.; Denys, H.; more...
    Geburtshilfe und Frauenheilkunde (2020)

    Fulltext@MSK | Save
  • Activating mutations in uveal melanoma convey sensitivity to g-alpha q inhibition
    Meeting Abstract

    Hitchman, T. D.; Ceraudo, E.; Moore, A. R.; Shoushtari, A. N.; Francis, J. H.; Guan, Y.; Chen, J.; Chang, M. T.; Taylor, B. S.; Sakmar, T. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York
    Meeting Abstract

    Robine, N.; Froeling, F.; Hubert, B.; Zody, M. C.; Oschwald, D.; Varmus, H.; Sawyers, C.; Tuveson, D.
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Targeting melanoma metabolism to overcome resistance to treatment
    Meeting Abstract

    Betoff, A.; Zippin, J.; Merghoub, T.; Chapman, P. B.; Wolchok, J.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series)
    Meeting Abstract

    Tarhini, A. A.; Betof Warner, A.; Johnson, M.; Kang, B.; Nakasato, A.; Vance, M.; Ling, Y. L.; Tang, J.; Patel, J.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease
    Meeting Abstract

    Bharmal, M.; Nolte, S.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Real world (RW) sequencing outcomes with immunotherapy and targeted therapy (TT) in BRAF+ metastatic melanoma (The NOBLE study series)
    Meeting Abstract

    Betof Warner, A.; Tarhini, A. A.; Johnson, M.; Kang, B.; Nakasato, A.; Vance, M.; Ling, Y. L.; Tang, J.; Patel, J.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib + dostarlimab in patients with platinum-resistant ovarian cancer
    Meeting Abstract

    Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; O'Cearbhaill, R. E.; Gaillard, S.; Adams, S.; Cappuccini, F.; Huang, M.; Chon, H. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of niraparib in older patients (pts) with advanced ovarian cancer (OC): Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Meeting Abstract

    Valabrega, G.; Pothuri, B.; Oaknin, A.; Graybill, W.; Sánchez, A. B.; McCormick, C.; Baurain, J. F.; Hoskins, P.; Denys, H.; O'Cearbhaill, R. E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical and immune responses to immunotherapy in biochemically recurrent (non-metastatic castration sensitive) prostate cancer (BCRpc)
    Meeting Abstract

    Madan, R. A.; Slovin, S.; Harshman, L. C.; Wei, X. X.; Bilusic, M.; Karzai, F. H.; Donahue, R. N.; Toney, N. J.; Strauss, J.; Cordes, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save